| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of
*
Microbiology and Immunology and
Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia; and
Department of Pathology and Immunology, Monash University, Prahran, Victoria, Australia
Glucocorticoid (GC) hormones cause pronounced T cell apoptosis, particularly in immature thymic T cells. This is possibly due to tissue-specific regulation of the glucocorticoid receptor (GR) gene. In mice the GR gene is transcribed from five separate promoters designated: 1A, 1B, 1C, 1D, and 1E. Nearly all cells express GR from promoters 1B–1E, but the activity of the 1A promoter has only been reported in the whole thymus or lymphocyte cell lines. To directly assess the role of GR promoter use in sensitivity to glucocorticoid-induced cell death, we have compared the activity of the GR 1A promoter with GC sensitivity in different mouse lymphocyte populations. We report that GR 1A promoter activity is restricted to thymocyte and peripheral lymphocyte populations and the cortex of the brain. The relative level of expression of the 1A promoter to the 1B–1E promoters within a lymphocyte population was found to directly correlate with susceptibility to GC-induced cell death, with the extremely GC-sensitive CD4+CD8+ thymocytes having the highest levels of GR 1A promoter activity, and the relatively GC-resistant 
TCR+CD24int/low thymocytes and peripheral T cells having the lowest levels. DNA sequencing of the mouse GR 1A promoter revealed a putative glucocorticoid-response element. Furthermore, GR 1A promoter use and GR protein levels were increased by GC treatment in thymocytes, but not in splenocytes. These data suggest that tissue-specific differences in GR promoter use determine T cell sensitivity to glucocorticoid-induced cell death.
This article has been cited by other articles:
|
|
 |
|
  J. A. Meyers, J. Taverna, J. Chaves, A. Makkinje, and A. Lerner Phosphodiesterase 4 Inhibitors Augment Levels of Glucocorticoid Receptor in B Cell Chronic Lymphocytic Leukemia but Not in Normal Circulating Hematopoietic Cells Clin. Cancer Res., August 15, 2007; 13(16): 4920 - 4927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Russcher, V. A S H Dalm, F. H de Jong, A. O Brinkmann, L. J Hofland, S. W J Lamberts, and J. W Koper Associations between promoter usage and alternative splicing of the glucocorticoid receptor gene J. Mol. Endocrinol., January 1, 2007; 38(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Teachey, D. A. Obzut, K. Axsom, J. K. Choi, K. C. Goldsmith, J. Hall, J. Hulitt, C. S. Manno, J. M. Maris, N. Rhodin, et al. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS) Blood, September 15, 2006; 108(6): 1965 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. E. Tissing, J. P. P. Meijerink, B. Brinkhof, M. J. C. Broekhuis, R. X. Menezes, M. L. den Boer, and R. Pieters Glucocorticoid-induced glucocorticoid-receptor expression and promoter usage is not linked to glucocorticoid resistance in childhood ALL Blood, August 1, 2006; 108(3): 1045 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ranta, D. Avram, S. Berchtold, M. Dufer, G. Drews, F. Lang, and S. Ullrich Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes, May 1, 2006; 55(5): 1380 - 1390. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. V. Sionov, O. Cohen, S. Kfir, Y. Zilberman, and E. Yefenof Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis J. Exp. Med., January 23, 2006; 203(1): 189 - 201. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
